Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial.
Saved in:
| Title: | Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial. |
|---|---|
| Authors: | Koshino A; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands.; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan., Neuen BL; The George Institute for Global Health, UNSW Sydney, Sydney, Australia., Jongs N; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands., Pollock C; Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Sydney, Australia.; Royal North Shore Hospital, St Leonards, NSW, Australia., Greasley PJ; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden., Andersson EM; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden., Hammarstedt A; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden., Karlsson C; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden., Langkilde AM; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden., Wada T; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands. h.j.lambers.heerspink@umcg.nl.; The George Institute for Global Health, UNSW Sydney, Sydney, Australia. h.j.lambers.heerspink@umcg.nl. |
| Source: | Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Nov 28; Vol. 22 (1), pp. 330. Date of Electronic Publication: 2023 Nov 28. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1475-2840 |
|---|---|
| DOI: | 10.1186/s12933-023-02027-8 |
